StockVS

OTC Markets · Medical Devices · USD

STRATA Skin Sciences, Inc. (SSKN) Stock Analysis

STRATA Skin Sciences, Inc. (SSKN) is a Medical Devices stock listed on OTC Markets and quoted in US Dollar.

SSKN

$0.00

−$0.00 (−96.00%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare SSKN with… →

SSKN Key Statistics

As of Sep 4, 2026
Trading
Open
$0.00
Previous Close
$0.01
Volume
175
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.03
Valuation
Market Cap
$29.44K
P/E Ratio
unprofitable
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
0.03
EPS (ttm)Profit attributable to each share over the last twelve months.
−1.35
Financials (FY)
Revenue (FY)
$30.70M−8.54%
Net Income (FY)
−$6.26M
Profit marginThe share of revenue left as profit after all costs and taxes.
−20.40%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
5.89M
1-Year Return
−99.99%
Dividend and dates
Avg Volume
4.84K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

SSKN Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−99.98%
2025−56.70%
2024+428.99%
2023−30.38%
2022−46.07%
2021−2.33%
2020−27.88%
2019−20.00%
2018+111.38%
2017−44.09%
2016 (partial year)−31.27%

As of September 4, 2026.

SSKN Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$30.70M−$6.26M−20.4%
2024$33.56M−$10.09M−30.1%
2023$33.36M−$10.83M−32.5%
2022$36.16M−$5.55M−15.3%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$30.70M$17.88M−$5.84M−$6.26M−20.4%
2024$33.56M$19.22M−$4.99M−$10.09M−30.1%
2023$33.36M$18.46M−$6.32M−$10.83M−32.5%
2022$36.16M$21.77M−$4.65M−$5.55M−15.3%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

SSKN Valuation vs Medical Devices Median

Median of 151 stocks
MetricSSKNMedical Devices medianvs median
P/S ratio0.002.980.0x the median
Profit margin−20.40%−1.69%18.7 pts below

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

STRATA Skin Sciences, Inc. (SSKN) carries a market capitalisation of $29.44K. The company sits in the Healthcare sector, in the Medical Devices industry. The company reports 114 employees.

The most recent close on file for SSKN is $0.00, dated September 4, 2026. That is $0.00 (−96.00%) against the previous close.

Financial Health

In fiscal 2025, STRATA Skin Sciences, Inc. reported revenue of $30.70M. Against the prior fiscal year total of $33.56M, that is a change of −8.54%. The same year closed with a net loss of $6.26M. Profit margin runs at −20.4%. That is 18.7 percentage points below the Medical Devices median of −1.69%. Trailing earnings per share are −1.35.

Across the 4 fiscal years on file, revenue moves from $36.16M in 2022 to $30.70M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.03.

The trailing one-year price return is −99.99%. Measured over 10 years, that is −61.77% a year compounded. Beta against the wider market is reported at 0.03. Annualized volatility over the trailing 10 years is 1,620.29%.

Growth & Income

The record shows no dividend for SSKN.

Across the complete calendar years on file, 2024 returned +428.99% and 2025 returned −56.70%. Of the 9 complete calendar years on file, 2 finished higher. 2026 is still running; the price is −99.98% year to date.

Peer Comparison

STRATA Skin Sciences, Inc. (SSKN) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
STRATA Skin Sciences, Inc. SSKN $29.44K
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. STRATA Skin Sciences, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

View all Medical Devices stocks →

Popular Healthcare Stocks

View all Healthcare stocks →

About STRATA Skin Sciences, Inc.

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates through Dermatology Recurring Procedures and Dermatology Procedures Equipment segments. The company offers XTRAC excimer laser and VTRAC lamp systems, which are used in the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma; and TheraClear acne therapy system for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. It serves dermatologists and dermatological group clinics. The company was formerly known as MELA Sciences, Inc. and changed its name to STRATA Skin Sciences, Inc. in December 2015. STRATA Skin Sciences, Inc. was incorporated in 1989 and is headquartered in Horsham, Pennsylvania.

Visit website →